Inner Mongolia Furui Medical Science Co., Ltd. (300049.SZ)
CNY 33.48
(-2.08%)
CNY 33.48
(-2.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 304.88 Million | 189.46 Million | 208.31 Million | 200.15 Million | 256.22 Million | 78.34 Million |
| Net Income | 177.11 Million | 145.37 Million | 148.04 Million | 90.26 Million | 100.12 Million | 45.17 Million |
| Depreciation & Amortization | 80.89 Million | 72.39 Million | 67.05 Million | 69.34 Million | 50.99 Million | 44.85 Million |
| Deferred income taxes | -2.87 Million | -6.87 Million | -16.73 Million | -5.66 Million | -22.87 Million | 30.05 Million |
| Stock-based compensation | -14.44 Million | 24.86 Million | 16.73 Million | - | - | 39.85 Thousand |
| Change in working capital | 36.72 Million | -38.13 Million | -16.94 Million | 22.06 Million | 91.78 Million | -31.01 Million |
| Other non-cash items | 10.21 Million | 9.83 Million | 10.16 Million | 18.47 Million | 13.32 Million | 19.33 Million |
| Investing Cash Flow | -150.42 Million | -68.44 Million | -182.56 Million | -32.06 Million | -125.12 Million | -81.14 Million |
| Investments in PPE | -189.22 Million | -90.77 Million | -79.61 Million | -109.74 Million | -66.29 Million | -93.96 Million |
| Acquisitions | 827.16 Thousand | 1.85 Million | 2 Million | 703.16 Thousand | 5.55 Million | 4380.90 |
| Investment purchases | -383.58 Million | -102.36 Million | -223.97 Million | -41.87 Million | -103.6 Million | -71.72 Million |
| Sales/Maturities of investments | 382 Million | 111.2 Million | 119.13 Million | 116.17 Million | 39.21 Million | 93.18 Million |
| Other Investing Activities | 36.82 Million | 11.62 Million | -116.87 Thousand | 2.67 Million | 3619.30 | -8.64 Million |
| Financing Cash Flow | -137.14 Million | -126.53 Million | 7.58 Million | 1.39 Million | -35.8 Million | -415.41 Million |
| Debt repayment | -4.34 Million | -51.12 Million | -69.88 Million | -109.54 Million | -71.75 Million | -177.84 Million |
| Dividends payments | -53.41 Million | -71.41 Million | -1.94 Million | -3.75 Million | -2.96 Million | -31.13 Million |
| Common Stock Repurchased | - | - | - | - | - | -66.99 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.95 Million | -3.99 Million | 79.42 Million | 114.69 Million | 38.91 Million | -206.44 Million |
| Accounts receivables | -24.59 Million | -94.92 Million | -84.99 Million | 45.69 Million | 69.51 Million | -95.58 Million |
| Accounts payables | 68.82 Million | 66.75 Million | 84.99 Million | -28.98 Million | 45.7 Million | 67.31 Million |
| Inventory | -4.62 Million | -3.09 Million | 4.16 Million | 11.02 Million | -565.11 Thousand | -31.51 Million |
| Other working capital | 65.94 Million | -6.87 Million | -21.11 Million | -5.66 Million | -22.87 Million | 505.73 Thousand |
| Cash at beginning of period | 479.21 Million | 472.72 Million | 467.9 Million | 299.07 Million | 202.23 Million | 619.01 Million |
| Cash at end of period | 509.58 Million | 479.21 Million | 472.72 Million | 467.9 Million | 299.07 Million | 202.23 Million |
| Capital Expenditure | -189.22 Million | -90.77 Million | -79.61 Million | -109.74 Million | -66.29 Million | -93.96 Million |
| Effect of forex changes on cash | 13.05 Million | 12.01 Million | -28.51 Million | -657.74 Thousand | 1.54 Million | 1.43 Million |
| Net cash flow / Change in cash | 30.37 Million | 6.48 Million | 4.81 Million | 168.82 Million | 96.84 Million | -416.77 Million |
| Free Cash Flow | 115.66 Million | 98.68 Million | 128.69 Million | 90.4 Million | 189.93 Million | -15.61 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 26.63 Million | 32.64 Million | 42.71 Million | 29.41 Million | 177.11 Million | 29.34 Million |
| Depreciation & Amortization | - | 23.5 Million | 23.5 Million | 24.91 Million | 80.89 Million | -38.28 Million |
| Deferred income taxes | - | - | - | - | -2.87 Million | 5.4 Million |
| Stock-based compensation | - | 7.87 Million | - | -14.44 Million | -14.44 Million | -8.12 Million |
| Change in working capital | - | -22.81 Million | - | -29.21 Million | 36.72 Million | 41.01 Million |
| Other non-cash items | -7.82 Million | 57.92 Million | -4.23 Million | -29.41 Million | 10.21 Million | 51.99 Million |
| Investing Cash Flow | -88.89 Million | 67.83 Million | -58.53 Million | -106.79 Million | -150.42 Million | -29.04 Million |
| Investments in PPE | -65.1 Million | -43.78 Million | -37.2 Million | -47.85 Million | -189.22 Million | -75.39 Million |
| Acquisitions | 5.84 Million | 1.14 Million | 1.34 Million | -20.14 Million | 827.16 Thousand | 21.19 Million |
| Investment purchases | -227 Million | -100.51 Million | -70 Million | -154.71 Million | -383.58 Million | -60.92 Million |
| Sales/Maturities of investments | 210.59 Million | 210.69 Million | 12.42 Million | 114.75 Million | 382 Million | 76.17 Million |
| Other Investing Activities | -7.38 Million | 291.51 Thousand | 34.9 Million | -309.18 Thousand | 36.82 Million | 9.9 Million |
| Financing Cash Flow | 10.25 Million | -17.4 Million | 8.56 Million | -35.26 Million | -137.14 Million | -42.17 Million |
| Debt repayment | -3.58 Million | -17.15 Million | -9.55 Million | -14.49 Million | -4.34 Million | -545.46 Thousand |
| Dividends payments | -39.74 Million | -541.62 Thousand | -702.91 Thousand | -41.61 Million | -53.41 Million | -41.46 Million |
| Common Stock Repurchased | - | - | - | -1.55 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 53.58 Million | -251.62 Thousand | -290 Thousand | -9.26 Million | -5.95 Million | -158.14 Thousand |
| Accounts receivables | - | -8.5 Million | - | -24.59 Million | -24.59 Million | -12.22 Million |
| Accounts payables | - | - | - | - | 68.82 Million | - |
| Inventory | - | -22.18 Million | - | -4.62 Million | -4.62 Million | 23.25 Million |
| Other working capital | - | 7.87 Million | - | - | - | 29.98 Million |
| Cash at beginning of period | 611.02 Million | 492.9 Million | 509.58 Million | 541.92 Million | 479.21 Million | 540.44 Million |
| Cash at end of period | 547.34 Million | 611.02 Million | 492.9 Million | 509.58 Million | 509.58 Million | 541.92 Million |
| Capital Expenditure | -65.1 Million | -43.78 Million | -37.2 Million | -47.85 Million | -189.22 Million | -75.39 Million |
| Effect of forex changes on cash | -1.81 Million | 1.54 Million | -5.18 Million | 6.22 Million | 13.05 Million | -8.64 Million |
| Net cash flow / Change in cash | -63.68 Million | 118.12 Million | -16.68 Million | -32.33 Million | 30.37 Million | 1.48 Million |
| Free Cash Flow | -46.28 Million | 23.27 Million | 1.27 Million | 35.14 Million | 115.66 Million | 5.94 Million |
CALX
0828
RB6
3242
4548
7985